ARTICLE | Product Development
Leading with lung
Lung cancer, PD-1/PD-L1 take over ASCO
June 3, 2017 3:26 AM UTC
Lung cancer squeezed past breast cancer as the top indication at the American Society of Clinical Oncology meeting this year as targeted therapies duke it out within genetically defined subgroups, while immunotherapies seek their best molecular subpopulations, combination partner or both.
BioCentury analyzed the roughly 3,600 meeting abstracts related to clinical, preclinical, biomarker or basic cancer research released in advance of the meeting taking place June 2-6 in Chicago...